Skip to main content

Russell Investments Group, Ltd.

Position in KALV — KalVista Pharmaceuticals, Inc.

CIK 1692234 Seattle, WA

Position in KALV

as of Mar 31, 2026 · filed May 8, 2026
Position Value
$1,131,144
+$222,724 QoQ
Shares Held
56,192
-0.1% QoQ
Ownership
0.106%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#74
of 182 holders
Holding Since
Sep 2020
18 quarters on record
Voting authority Sole 99.91813781321184.ToString("F0")% Shared 0.ToString("F0")% None 0.0818621867881549.ToString("F0")%

Common Shares in KALV Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Russell Investments Group, Ltd. holds $1,223,802,944 across 266 Biotechnology names. KALV ranks #94 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in KALV

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,131,144 56,192
2025-12-31 $908,420 56,249
2025-09-30 $684,466 56,196
2025-06-30 $599,944 53,069
2025-03-31 $611,943 53,028
2024-12-31 $1,131,352 133,572
2024-09-30 $1,343,185 115,992
2024-06-30 $926,873 78,682
2023-06-30 $9,036 1,004
2023-03-31 $7,891 1,004
2022-12-31 $6,787 1,004
2022-09-30 $14,568 1,004
2021-12-31 $247,467 18,705
2021-09-30 $326,402 18,705
2021-06-30 $448,171 18,705
2021-03-31 $480,531 18,705
2020-12-31 $427,007 22,486
2020-09-30 $1,522,797 120,953